View our masking and visitation guidelines based on current rates of respiratory illnesses in the community.

Our new building on the hospital campus, Forest B, is open. Families and visitors can park in the new Forest B garage next to Emergency.

Clinical Trial Search block Test

Phase 2 Randomized, Double-blind, Placebocontrolled, Study of Zatolmilast (BPN14770) in Subjects with PPP2R5D Neurodevelopmental Disorder (Jordan's Syndrome)

Jordan's Syndrome Clinical Trial

Phase: II
Clinicaltrials.gov ID: NCT06717438

What is the goal of the study?

This is a multi-center, Phase 2, randomized, double-blind, placebo-controlled, study with an open label extension to obtain preliminary assessment of the effects of zatolmilast in patients with PPP2R5D neurodevelopmental disorder.

Who can participate in the study?

Everyone

Study Team:

PI (Study Doctor): Ghayda Mirzaa
Study Team Member: Emily Pao, emily.pao@seattlechildrens.org